
Concentra Group Holdings Parent, Inc.
CONNYSEHealthcare● Active
$25.46
+$0.14(+0.55%)
Market Cap$3.3B
P/E Ratio—
52W High$26.655
52W Low$18.545
Concentra Group Holdings Parent, Inc.(CON)· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · CON · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.17B | $0.17B | $0.18B | $0.17B | $0.22B |
| Depreciation & Amort. | $0.00B | $0.07B | $0.07B | $0.07B | $0.08B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | $0.01B | $0.03B | ($0.02B) | $0.03B | ($0.01B) |
| Net Cash from Operations | $0.28B | $0.27B | $0.23B | $0.27B | $0.29B |
| Investing Activities | |||||
| Capital Expenditure | ($0.08B) | ($0.06B) | ($0.07B) | ($0.05B) | ($0.05B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.41B) | ($0.07B) | ($0.08B) | ($0.06B) | ($0.06B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.02B) | ($0.02B) | ($0.01B) | ($0.03B) | $0.00B |
| Dividends Paid | ($0.03B) | ($1.54B) | ($0.01B) | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.09B | $1.00B | ($0.16B) | ($0.18B) | ($0.33B) |
| Net Cash from Financing | $0.03B | ($0.05B) | ($0.17B) | ($0.21B) | ($0.34B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.20B | $0.21B | $0.16B | $0.23B | $0.24B |
| FCF Margin %(computed) | 9.11% | 11.07% | 8.98% | 13.24% | 14.08% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · B
深入了解Concentra Group Holdings Parent, Inc.
关于Concentra Group Holdings Parent, Inc.(CON)现金流量表
Concentra Group Holdings Parent, Inc. 2025财年经营活动现金流$0.28B,自由现金流$0.20B(FCF利润率9.11%),资本支出($0.08B)。
常见问题
CON · 4 问Concentra Group Holdings Parent, Inc. 2025财年自由现金流$0.20B,同比down6.3%。
CON free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10